`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`
`LIQUIDIA TECHNOLOGIES, INC.,
`
`Petitioner
`
`v.
`
`UNITED THERAPEUTICS CORPORATION,
`
`Patent Owner.
`
`_______________
`
`Case IPR2021-00406
`U.S. Patent No. 10,716,793 B2
`Issue Date: July 21, 2020
`_______________
`
`____________________________________________________________
`
`Patent Owner’s Updated Mandatory Notices
`Under 37 C.F.R. § 42.8
`
`4891-8036-2760.1
`
`
`
`IPR2021-00406
`U.S. Patent No. 10,716,793
`
`
`Patent Owner Updated Mandatory Notices
`
`
`Patent Owner United Therapeutics Corporation hereby appoints the following
`
`practitioners as Patent Owner’s attorneys to transact all business in the United
`
`States Patent & Trademark Office/Patent Trial and Appeal Board associated with
`
`any Inter Partes Review for the above-captioned patent:
`
`LEAD COUNSEL
`Stephen B. Maebius
`Foley & Lardner LLP
`3000 K St., NW, Suite 600
`Washington, DC 20007
`Direct Line: 202-672-5569
`Email: smaebius@foley.com
`Fax: 202-672-5399
`USPTO Reg. No. 35,264
`
`
`
`
`
`BACK-UP COUNSEL
`Michael R. Houston
`Foley & Lardner LLP
`321 North Clark Street, Suite 3000
`Chicago, IL 60654-4762
`Direct Line: 312-832-4378
`Email: mhouston@foley.com
`Fax: 312-832-4700
`USPTO Reg. No. 58,486
`
`Jason N. Mock
`Foley & Lardner LLP
`3000 K St., NW, Suite 600
`Washington, DC 20007
`Direct Line: 202-295-4775
`Email: jmock@foley.com
`Fax: 202-672-5399
`USPTO Reg. No. 69,186
`
`Shaun R. Snader
`United Therapeutics Corp.
`1735 Connecticut Ave., NW, 2nd Floor
`Washington, DC 20009
`Direct Line: 202-304-1701
`Email: ssnader@unither.com
`USPTO Reg. No. 59,987
`
`4891-8036-2760.1
`
`1
`
`
`
`IPR2021-00406
`U.S. Patent No. 10,716,793
`
`LEAD COUNSEL
`
`
`
`
`
`
`Patent Owner Updated Mandatory Notices
`
`
`BACK-UP COUNSEL
`Douglas H. Carsten
`McDermott Will & Emery LLP
`18565 Jamboree Road
`Suite 250
`Irvine, CA 92612-2565
`Direct Line: 949-620-6111
`Email: dcarsten@mwe.com
`Fax: 949-666-9834
`USPTO Reg. No. 43,534
`
`April E. Weisbruch
`McDermott Will & Emery LLP
`The McDermott Building
`500 North Capitol Street, NW
`Washington, DC 20001-1531
`Direct Line: 202-756-8220
`Email: aweisbruch@mwe.com
`Fax: 202-756-8087
`USPTO Reg. No. 65,783
`
`Judy Mohr, Ph.D.
`McDermott Will & Emery LLP
`275 Middlefield Road, Suite 100
`Menlo Park, CA 94025-4004
`Direct Line: 650-815-7630
`Email: jmohr@mwe.com
`Fax: 650-815-7401
`USPTO Reg. No. 38,563
`
`
`4891-8036-2760.1
`
`2
`
`
`
`IPR2021-00406
`U.S. Patent No. 10,716,793
`
`LEAD COUNSEL
`
`
`
`
`
`
`
`
`
`
`4891-8036-2760.1
`
`Patent Owner Updated Mandatory Notices
`
`
`BACK-UP COUNSEL
`Arthur P. Dykhuis
`McDermott Will & Emery LLP
`18565 Jamboree Road, Suite 250
`Irvine, CA 92612-2565
`Direct Line: 949-989-8292
`Email: adykhuis@mwe.com
`Fax: 949-534-9905
`USPTO Reg. No. 68,325
`
`Jiaxiao Zhang
`McDermott Will & Emery LLP
`18565 Jamboree Road, Suite 250
`Irvine, CA 92612-2565
`Direct Line: 949-757-6398
`Email: jiazhang@mwe.com
`Fax: 949-851-9348
`USPTO Reg. No. 63,235
`
`Amy L. Mahan, Ph.D.
`McDermott Will & Emery LLP
`444 West Lake Street, Suite 4000
`Chicago, IL 60606-0029
`Direct Line: 312-984-7742
`Email: amahan@mwe.com
`Fax: 312-372-2000
`USPTO Reg. No. 75,997
`
`Mandy H. Kim
`McDermott Will & Emery LLP
`18565 Jamboree Rd #250
`Irvine, CA 92612
`Direct Line: 949- 757-6061
`Email: mhkim@mwe.com
`Fax: 949-534-9926
`
`
`3
`
`
`
`IPR2021-00406
`U.S. Patent No. 10,716,793
`
`
`I.
`
`Service Information Pursuant to 37 C.F.R. §§ 42.8(b)(4):
`
`Patent Owner Updated Mandatory Notices
`
`
`Please address all correspondence to the lead counsel at the address shown
`
`above. Patent Owner consents to electronic service by e-mail at:
`
`smaebius@foley.com
`
`UT-793@foley.com
`
`UTCvLiquidia-IPR@mwe.com
`
`Any questions concerning this paper may be directed to lead counsel.
`
`
`Dated: January 6, 2022
`
`
`
`
`
`Respectfully submitted,
`
`/Stephen B. Maebius/
`Stephen B. Maebius
`Registration No. 35,264
`Counsel for Patent Owner
`
`4891-8036-2760.1
`
`4
`
`
`
`IPR2021-00406
`U.S. Patent No. 10,716,793
`
`
`Patent Owner Updated Mandatory Notices
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing United
`
`Therapeutics Corporation’s Updated Mandatory Notices Under 37 C.F.R.
`
`§ 42.8 was served on January 6, 2022, by email directed to the attorneys of record
`
`for the Petitioner at the following addresses:
`
`ielrifi@cooley.com
`emilch@cooley.com
`dkannappan@cooley.com
`ssukduang@cooley.com
`zLiquidiaIPR@cooley.com
`
`By: /Stephen B. Maebius/
`Stephen B. Maebius
`Registration No. 35,264
`Counsel for Patent Owner
`
`
`
`
`
`
`
`
`Dated: January 6, 2022
`
`
`
`
`
`4891-8036-2760.1
`
`